Fluctuating weight in patients with atrial fibrillation (AF) participating in a weight management intervention was associated with increased antihypertensive medication requirements, higher fasting insulin and serum low-density lipoprotein levels, and adverse cardiac remodelling (Pathak et al., 2015). This evidence concerns the gene INS and atrial fibrillation.